EU-China Industry Meeting on Pharmaceuticals

2019-10-26 | Beijing, Shanghai

On 26 October, the European Chamber Pharmaceutical working group organized EU-China Industry Meeting on Pharmaceuticals in Amsterdam, the Netherlands, and hosted officials from the the National Medical Products Administration (NMPA), including Mr. Chen Shifei, Deputy Commissioner of the NMPA. 

35 members from 11 European pharmaceutical companies, as well as representatives from European Medicine Agency and European Union Delegation to China, participated in the meeting. Ms. Li Ye, National Chair of the Pharmaceutical working group, and Mr. Chen, delivered keynote speeches to the participants. In Mr. Chen's speech, he highlighted the progress that the NMPA has made in the past years such as improving efficiency of and optimizing drug review and approval process, the promulgation of the Vaccine Administration Law and the revision of the Drug Administration Law. He also emphasized that the enterprises, as marketing authorization holder, bear main responsibility to ensure the quality and safety of drugs and vaccines.

The keynote speeches were followed by three corporate presentations and a two-hour intensive discussion. In the discussion, the participants raised a number of critical issues such as further acceleration of drug registration, marketing authorization holder, DMF registration for APIs, excipients and packaging materials (AEPs), implementation of the ICH guidelines, etc.